Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. (Q47332928)

14 January 2018

title

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. (English)

1 reference

14 January 2018

author

Siobhain M O' Mahony

2

1 reference

14 January 2018

Paul D. Cotter

6

1 reference

14 January 2018

Timothy G. Dinan

7

1 reference

14 January 2018

John F. Cryan

8

1 reference

14 January 2018

Harriët Schellekens

3

object named as

Harriet Schellekens

1 reference

14 January 2018

4

Orla O'Sullivan

1 reference

14 January 2018

author name string

Kieran J Davey

1

1 reference

14 January 2018

John Bienenstock

5

1 reference

14 January 2018

language of work or name

1 reference

11 January 2012

1 reference

14 January 2018

number of pages

15

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

14 January 2018

volume

221

1 reference

14 January 2018

page(s)

155-169

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

https://scigraph.springernature.com/pub.10.1007/s00213-011-2555-2

exact match

0 references

cites work

Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Association between antipsychotics and weight gain among psychiatric outpatients in Pakistan: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Metabolic implications of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Preclinical models of antipsychotic drug-induced metabolic side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Gender differences in host defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Insulin resistance following continuous, chronic olanzapine treatment: an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Olanzapine plasma concentrations after treatment with 10, 20, and 40 mg/d in patients with schizophrenia: an analysis of correlations with efficacy, weight gain, and prolactin concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

A parametric analysis of olanzapine-induced weight gain in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Treatment of psychosis: 30 years of progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Weight gain and new onset diabetes associated with olanzapine and risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Lipogenic effects of psychotropic drugs: focus on the SREBP system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

SREBP-1c transcription factor and lipid homeostasis: clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Increased food intake and energy expenditure following administration of olanzapine to healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Gender difference in the composition of fecal flora in laboratory mice, as detected by denaturing gradient gel electrophoresis (DGGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Ghrelin secretion is modulated in a nutrient- and gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Are females at special risk of obesity if they become psychotic? The longitudinal Northern Finland 1966 Birth Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Gender effects in pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

How host-microbial interactions shape the nutrient environment of the mammalian intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

MEGAN analysis of metagenomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Clozapine-induced weight gain predicts improvement in psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Olanzapine increases plasma ghrelin level in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

A review of the effect of atypical antipsychotics on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Metabolic risk during antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Gender differences in the prescribing of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Simultaneous assessment of soil microbial community structure and function through analysis of the meta-transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Sensitivity of the female rat to olanzapine-induced weight gain--far from the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Current understanding of gender dimorphism in hepatic pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2555-2

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

21 January 2018

1 reference

12 December 2020

Gender differences in plasma ghrelin and its relations to body composition and bone ? an opposite-sex twin study

1 reference

12 December 2020

The microbiome-gut-brain axis: from bowel to behavior

1 reference

12 December 2020

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

1 reference

12 December 2020

[Comparative action of promethazine, chlorpromazine and cortisone in mice receiving fatal doses of a bacterial endotoxin]

1 reference

12 December 2020

Early differences in fecal microbiota composition in children may predict overweight.

1 reference

12 December 2020

Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?

1 reference

12 December 2020

Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.

1 reference

12 December 2020

Hypothalamic histamine neurons activate lipolysis in rat adipose tissue.

1 reference

12 December 2020

Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.

1 reference

12 December 2020

Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels

1 reference

12 December 2020

Gender differences in pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

1 reference

12 December 2020

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

12 December 2020

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

1 reference

12 December 2020

[Differences between men and women in side effects of second-generation antipsychotics]

1 reference

12 December 2020

Sex-specific differences in side effects of psychotropic drugs: genes or gender?

1 reference

12 December 2020

Atypical antipsychotics and weight gain in Chinese patients: a comparison of olanzapine and risperidone.

1 reference

12 December 2020

SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?

1 reference

12 December 2020

Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities

1 reference

12 December 2020

Long-term treatment of ghrelin stimulates feeding, fat deposition, and alters the GH/IGF-I axis in the tilapia, Oreochromis mossambicus

1 reference

12 December 2020

Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine

1 reference

12 December 2020

10.1007/S00213-011-2555-2

Identifiers

DOI

1 reference

14 January 2018

PubMed ID

22234378

1 reference

14 January 2018